Delivery Order SPE2DR25D2214-SPE2DR26FV7A1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,561.38 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product. The contract, designated as a firm fixed price delivery order with no set-aside, was awarded on May 6, 2025, with an ultimate completion date of May 7, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $18,783.85 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for Orencia Clickject 125 mg/mL, a pharmaceutical product for federal medical procurement. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $17,353.57 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. The contract, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $38,221.51 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product, with completion scheduled for November 14, 2025. This firm fixed-price delivery order, awarded on November 13, 2025, was not set aside for small businesses or other designated groups, indicating it was competitively awarded. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $64,325.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in treating autoimmune conditions. This non-set-aside contract was competitively awarded on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $5,501.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-set-aside award was made to the company's Corporate Office located in Conshohocken, Pennsylvania, representing a single line-item delivery of this pharmaceutical product. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,594.03 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price contract represents a non-competitive delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $37,093.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orencia ClickJect 125 mg/ml. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), requires performance completion by October 23, 2025. This delivery order was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a $7,188.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion targeted for September 9, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,664.23 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on November 3, 2025, with ultimate completion on November 4, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV7A1Delivery Order
The Defense Logistics Agency awarded a $22,371.18 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product, on December 18, 2025, with completion scheduled for December 19, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's $999,999,999.00 prime IDC with DLA Troop Support Medical (SPE2DX) that extends through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive vehicle to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The company's established role as a primary vendor positions it to continue supporting Department of Defense pharmaceutical procurement requirements under the planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 12/17/25 |